FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch

The U.S. Food and Drug Administration approved DexCom, Inc.’s DXCM Dexcom G7 15-Day Continuous Glucose Monitoring System for people over 18 with diabetes.With an overall Mean Absolute Relative Difference (MARD) of 8.0%, Dexcom G7 15 Day builds on the performance of Dexcom CGM, which is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range.Also Read: Trump Tariffs Spare Drugmakers But Threaten Diabetes Device IndustryNew with Dexcom G7 15 DayLongest lasting CGM system wit ...